Toxin profiles and antimicrobial resistance patterns among toxigenic clinical isolates of Clostridioides (Clostridium) difficile

سال انتشار: 1398
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 312

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-22-7_015

تاریخ نمایه سازی: 20 مهر 1398

چکیده مقاله:

Objective(s): Clostridioides (Clostridium) difficile infection as a healthcare-associated infection can cause life-threatening infectious diarrhea in hospitalized patients. The aim of this study was to investigate the toxin profiles and antimicrobial resistance patterns of C. difficile isolates obtained from hospitalized patients in Shiraz, Iran.Materials and Methods: This study was performed on 45 toxigenic C. difficile isolates. Determination of toxin profiles was done using polymerase chain reaction method. Antimicrobial susceptibility to vancomycin, metronidazole, clindamycin, tetracycline, moxifloxacin, and chloramphenicol was determined by the agar dilution method. The genes encoding antibiotic resistance were detected by the standard procedures.Results: The most frequent toxin profile was tcdA+, tcdB+, cdtAˉ, cdtBˉ (82.2%), and only one isolate harboured all toxin associated genes (tcdA+, tcdB+, cdtA+, cdtB+) (2.2%). The genes encoding CDT (binary toxin) were also found in six (13.3%) isolates. Resistance to tetracycline, clindamycin and moxifloxacin was observed in 66.7%, 60% and 42.2% of the isolates, respectively. None of the strains showed resistance to other antibiotics. The distribution of the ermB gene (the gene encoding resistance to clindamycin) was 57.8% and the tetM and tetW genes (the genes encoding resistance to tetracycline) were found in 62.2% and 13.3% of the isolates, respectively. The substitutions Thr82 to Ile in GyrA and Asp426 to Asn in GyrB were seen in moxifloxacin resistant isolates.Conclusion: Our data contributes to the present understanding of virulence and resistance traits amongst the isolates. Infection control strategies should be implemented carefully in order to curb the dissemination of C. difficile strains in hospital.

نویسندگان

Hamid Heidari

Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Hadi Sedigh Ebrahim-Saraie

Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Ali Amanati

Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Mohammad Motamedifar

Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran|Shiraz HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Berger FK, Rasheed SS, Araj GF, Mahfouz R, Rimmani HH, ...
  • Lim SC, Androga GO, Knight DR, Moono P, Foster NF, ...
  • Janoir C. Virulence factors of Clostridium difficile and their role ...
  • Aktories K, Papatheodorou P, Schwan C. Binary Clostridium difficile toxin ...
  • Tokimatsu I, Shigemura K, Osawa K, Kinugawa S, Kitagawa K, ...
  • Stubbs S, Rupnik M, Gibert M, Brazier J, Duerden B, ...
  • Huang H, Weintraub A, Fang H, Nord CE. Antimicrobial resistance ...
  • Peng Z, Jin D, Kim HB, Stratton CW, Wu B, ...
  • Abuderman AA, Mateen A, Syed R, Sawsan Aloahd M. Molecular ...
  • Yang J, Zhang X, Liu X, Cai L, Feng P, ...
  • Spigaglia P, Mastrantonio P. Comparative analysis of Clostridium difficile clinical ...
  • Sedigh Ebrahim-Saraie H, Heidari H, Amanati A, BazarganiA, Alireza Taghavi ...
  • Jamal W, Pauline E, Rotimi V. A prospective study of ...
  • Jamal WY, Rotimi VO. Surveillance of antibiotic resistance among hospital- ...
  • Lemee L, Dhalluin A, Testelin S, Mattrat MA, Maillard K, ...
  • Terhes G, Urban E, Soki J, Hamid KA, Nagy E. ...
  • Wayne PA. Performance standards for antimicrobial susceptibility testing. Clinical and ...
  • The european committee on antimicrobial susceptibility testing. Breakpoint tables for ...
  • Trinh S, Reysset G. Detection by PCR of the nim ...
  • Fry PR, Thakur S, Abley M, Gebreyes WA. Antimicrobial resistance, ...
  • Spigaglia P, Barbanti F, Mastrantonio P, Brazier JS, Barbut F, ...
  • Karlowsky JA, Adam HJ, Kosowan T, Baxter MR, Nichol KA, ...
  • Costa CL, Mano de Carvalho CB, Gonzalez RH, Gifoni MAC, ...
  • Weber I, Riera E, Deniz C, Perez JL, Oliver A, ...
  • Vaishnavi C, Singh M, Mahmood S, Kochhar R. Prevalence and ...
  • Rezazadeh Zarandi E, Mansouri S, Nakhaee N, Sarafzadeh F, Iranmanesh ...
  • Goncalves C, Decre D, Barbut F, Burghoffer B, Petit JC. ...
  • Krutova M, Nyc O, Matejkova J, Allerberger F, Wilcox MH, ...
  • Cejas D, Rios Osorio NR, Quiros R, Sadorin R, Berger ...
  • Liu XS, Li WG, Zhang WZ, Wu Y, Lu JX. ...
  • Luo Y, Zhang W, Cheng JW, Xiao M, Sun GR, ...
  • Peng Z, Addisu A, Alrabaa S, Sun X. Antibiotic resistance ...
  • Androga GO, Knight DR, Lim SC, Foster NF, Riley TV. ...
  • Jimenez A, Araya R, Paniagua D, Camacho-Mora Z, Du T, ...
  • Gao Q, Wu S, Huang H, Ni Y, Chen Y, ...
  • Hidalgo-Villeda F, Tzoc E, Torres L, Bu E, Rodriguez C, ...
  • Rodriguez C, Fernandez J, Van Broeck J, Taminiau B, Avesani ...
  • Hampikyan H, Bingol EB, Muratoglu K, Akkaya E, Cetin O, ...
  • Goudarzi M, Goudarzi H, Alebouyeh M, Azimi Rad M, Shayegan ...
  • Freeman J, Vernon J, Pilling S, Morris K, Nicholson S, ...
  • Freeman J, Vernon J, Morris K, Nicholson S, Todhunter S, ...
  • Kuwata Y, Tanimoto S, Sawabe E, Shima M, Takahashi Y, ...
  • Cheng JW, Yang QW, Xiao M, Yu SY, Zhou ML, ...
  • نمایش کامل مراجع